Giving letter grades for 2013 pharma performance

Eric Palmer

Anyone can judge drugmakers' annual results by the numbers: top line, bottom line, growth, earnings or some combination of financial markers. It's more daring to step up with a grade that factors in all of a company's highs and lows. Still, one long-time watcher has decided to do it, using the old school of A, B and C.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS